Novogen (NASDAQ:KZIA) Announces Quarterly Earnings Results

Novogen (NASDAQ:KZIA) posted its earnings results on Thursday. The company reported ($1.34) earnings per share for the quarter, FiscalAI reports.

Novogen Stock Up 5.3%

Novogen stock traded up $0.40 on Thursday, reaching $7.91. 116,460 shares of the stock were exchanged, compared to its average volume of 214,072. Novogen has a twelve month low of $2.86 and a twelve month high of $17.40. The firm has a fifty day moving average price of $6.96 and a two-hundred day moving average price of $7.78.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. HC Wainwright reissued a “buy” rating and set a $18.00 price objective on shares of Novogen in a report on Wednesday, January 28th. Weiss Ratings restated a “sell (d-)” rating on shares of Novogen in a report on Thursday, January 22nd. Finally, Wall Street Zen cut Novogen from a “buy” rating to a “hold” rating in a research report on Sunday, March 8th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $19.00.

Novogen Company Profile

Novogen (NASDAQ:KZIA) is a clinical-stage biotechnology company focused on the discovery and development of novel small-molecule therapeutics for the treatment of cancer. The company’s pipeline includes GDC-0084, a brain-penetrant phosphoinositide 3-kinase (PI3K) inhibitor in Phase II development for glioblastoma, as well as Cantrixil, an orally bioavailable small molecule designed to target treatment-resistant ovarian cancer stem cells. Novogen’s research efforts leverage structure-based drug design to optimize selectivity and pharmacokinetic profiles, seeking to address high-unmet medical needs in oncology.

Founded in Australia and now headquartered in New York City, Novogen maintains research facilities in Perth and collaborates with academic institutions and contract research organizations worldwide.